Brief: Matinas Biopharma Says On Feb 19, Provided Notice Of Its Termination Of Controlled Equity Offering Sales Agreement
20/02/2020 12:22
Feb 20 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA HOLDINGS - ON FEB 19, CO PROVIDED NOTICE
OF
ITS TERMINATION OF CONTROLLED EQUITY OFFERING SALES AGREEMENT,
DATED AS OF APRIL 28, 2017
* MATINAS BIOPHARMA HOLDINGS - TERMINATION OF EQUITY SALES
AGREEMENT BETWEEN CO AND CANTOR FITZGERALD TO BE EFFECTIVE ON OR
BEFORE MARCH 1, 2020
Source (https://bit.ly/37L9J49)
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing